{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T11:04:55Z","timestamp":1772881495248,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.tox.2025.154245","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T17:00:40Z","timestamp":1754413240000},"page":"154245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Maternal, fetal, and neonatal toxicity and potency estimates of perfluorohexane sulfonate (PFHxS) from oral maternal exposure in the Sprague-Dawley rat"],"prefix":"10.1016","volume":"518","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6622-5769","authenticated-orcid":false,"given":"Justin M.","family":"Conley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0538-5157","authenticated-orcid":false,"given":"Christy S.","family":"Lambright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9558-3514","authenticated-orcid":false,"given":"Nicola","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Bangma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jermaine","family":"Ford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth Medlock","family":"Kakaley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"L. Earl","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1-2","key":"10.1016\/j.tox.2025.154245_bib1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.mce.2012.10.027","article-title":"\"Nuclear receptors, bile acids and cholesterol homeostasis series - bile acids and pregnancy","volume":"368","author":"Abu-Hayyeh","year":"2013","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.tox.2025.154245_bib2","unstructured":"ATSDR, 2021. Toxicological profile for perfluoroalkyls. US DHHS. https:\/\/www.atsdr.cdc.gov\/toxprofiles\/tp200.pdf."},{"issue":"2","key":"10.1016\/j.tox.2025.154245_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00431-013-2157-6","article-title":"\"Pediatric non-alcoholic fatty liver disease: an increasing public health issue","volume":"173","author":"Berardis","year":"2014","journal-title":"Eur. J. Pedia"},{"key":"10.1016\/j.tox.2025.154245_bib4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.envint.2014.04.010","article-title":"\"Maternal serum concentrations of per- and polyfluoroalkyl substances and their predictors in years with reduced production and use","volume":"69","author":"Berg","year":"2014","journal-title":"Environ. Int"},{"key":"10.1016\/j.tox.2025.154245_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2022.107727","article-title":"\"Internal relative potency factors based on immunotoxicity for the risk assessment of mixtures of per- and polyfluoroalkyl substances (PFAS) in human biomonitoring","volume":"171","author":"Bil","year":"2023","journal-title":"Environ. Int"},{"issue":"7","key":"10.1016\/j.tox.2025.154245_bib6","doi-asserted-by":"crossref","first-page":"77005","DOI":"10.1289\/EHP10009","article-title":"\"Internal relative potency factors for the risk assessment of mixtures of Per- and polyfluoroalkyl substances (PFAS) in human biomonitoring","volume":"130","author":"Bil","year":"2022","journal-title":"Environ. Health Perspect."},{"issue":"3","key":"10.1016\/j.tox.2025.154245_bib7","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/etc.4835","article-title":"\"Risk assessment of Per- and polyfluoroalkyl substance mixtures: a relative potency factor approach","volume":"40","author":"Bil","year":"2021","journal-title":"Environ. Toxicol. Chem."},{"issue":"1","key":"10.1016\/j.tox.2025.154245_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12940-020-00647-1","article-title":"\"Exposure to perflouroalkyl acids and foetal and maternal thyroid status: a review","volume":"19","author":"Boesen","year":"2020","journal-title":"Environ. Health"},{"issue":"3-4","key":"10.1016\/j.tox.2025.154245_bib9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.reprotox.2009.01.004","article-title":"\"Evaluation of potential reproductive and developmental toxicity of potassium perfluorohexanesulfonate in sprague dawley rats","volume":"27","author":"Butenhoff","year":"2009","journal-title":"Reprod. Toxicol."},{"issue":"11","key":"10.1016\/j.tox.2025.154245_bib10","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1289\/ehp.10598","article-title":"\"Polyfluoroalkyl chemicals in the U.S. Population: data from The National health and nutrition examination survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000","volume":"115","author":"Calafat","year":"2007","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tox.2025.154245_bib11","unstructured":"CDC,\u00a02009. Fourth National Report on Human Exposure to Environmental Chemicals. US DHHS. https:\/\/stacks.cdc.gov\/view\/cdc\/105346."},{"key":"10.1016\/j.tox.2025.154245_bib12","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.reprotox.2018.04.007","article-title":"\"Reproductive and developmental toxicity of potassium perfluorohexanesulfonate in CD-1 mice","volume":"78","author":"Chang","year":"2018","journal-title":"Reprod. Toxicol."},{"issue":"1","key":"10.1016\/j.tox.2025.154245_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ijgo.2013.02.015","article-title":"\"Primary bile acids as potential biomarkers for the clinical grading of intrahepatic cholestasis of pregnancy","volume":"122","author":"Chen","year":"2013","journal-title":"Int J. Gynaecol. Obstet."},{"issue":"3","key":"10.1016\/j.tox.2025.154245_bib14","doi-asserted-by":"crossref","first-page":"37008","DOI":"10.1289\/EHP4372","article-title":"\"Adverse maternal, fetal, and postnatal effects of hexafluoropropylene oxide dimer acid (GenX) from oral gestational exposure in Sprague-Dawley rats","volume":"127","author":"Conley","year":"2019","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tox.2025.154245_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2020.106204","article-title":"\"Hexafluoropropylene oxide-dimer acid (HFPO-DA or GenX) alters maternal and fetal glucose and lipid metabolism and produces neonatal mortality, low birthweight, and hepatomegaly in the Sprague-Dawley rat","volume":"146","author":"Conley","year":"2021","journal-title":"Environ. Int"},{"key":"10.1016\/j.tox.2025.154245_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2022.107631","article-title":"\"Cumulative maternal and neonatal effects of combined exposure to a mixture of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) during pregnancy in the Sprague-Dawley rat","volume":"170","author":"Conley","year":"2022","journal-title":"Environ. Int"},{"key":"10.1016\/j.tox.2025.154245_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2021.107056","article-title":"\"Developmental toxicity of nafion byproduct 2 (NBP2) in the Sprague-Dawley rat with comparisons to hexafluoropropylene oxide-dimer acid (HFPO-DA or GenX) and perfluorooctane sulfonate (PFOS)","volume":"160","author":"Conley","year":"2022","journal-title":"Environ. Int"},{"key":"10.1016\/j.tox.2025.154245_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2023.164609","article-title":"\"Dose additive maternal and offspring effects of oral maternal exposure to a mixture of three PFAS (HFPO-DA, NBP2, PFOS) during pregnancy in the Sprague-Dawley rat","volume":"892","author":"Conley","year":"2023","journal-title":"Sci. Total Environ."},{"issue":"Pt 3","key":"10.1016\/j.tox.2025.154245_bib19","article-title":"\"Long-chain perfluoroalkylether carboxylic acids PFO5DoA and PFO4DA alter glucose, bile acid, and thyroid hormone homeostasis in fetal rats from 5-day maternal oral exposure","volume":"263","author":"Conley","year":"2024","journal-title":"Environ. Res"},{"issue":"2","key":"10.1016\/j.tox.2025.154245_bib20","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1021\/acs.est.3c08559","article-title":"\"Maternal and neonatal effects of maternal oral exposure to Perfluoro-2-methoxyacetic acid (PFMOAA) during pregnancy and early lactation in the Sprague-Dawley rat","volume":"58","author":"Conley","year":"2024","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.tox.2025.154245_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.tox.2016.12.007","article-title":"\"Perfluoroalkyl acids-induced liver steatosis: effects on genes controlling lipid homeostasis","volume":"378","author":"Das","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2025.154245_bib22","unstructured":"EU Commission, 2024. Technical guidelines regarding methods of analysis for monitoring of per- and polyfluoroalkyl substances (PFAS) in water intended for human consumption. C\/2024\/4910. https:\/\/eur-lex.europa.eu\/eli\/dir\/2020\/2184\/oj."},{"key":"10.1016\/j.tox.2025.154245_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.116136","article-title":"\"In vitro activity of a panel of per- and polyfluoroalkyl substances (PFAS), fatty acids, and pharmaceuticals in peroxisome proliferator-activated receptor (PPAR) alpha, PPAR gamma, and estrogen receptor assays","volume":"449","author":"Evans","year":"2022","journal-title":"Toxicol. Appl. Pharm."},{"issue":"3","key":"10.1016\/j.tox.2025.154245_bib24","doi-asserted-by":"crossref","first-page":"R87","DOI":"10.1530\/JOE-14-0025","article-title":"\"Thyroid hormones in fetal growth and prepartum maturation","volume":"221","author":"Forhead","year":"2014","journal-title":"J. Endocrinol."},{"issue":"2","key":"10.1016\/j.tox.2025.154245_bib25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/10408444.2021.1888073","article-title":"\"Systemic PFOS and PFOA exposure and disturbed lipid homeostasis in humans: what do we know and what not?\"","volume":"51","author":"Fragki","year":"2021","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.tox.2025.154245_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/srep38039","article-title":"\"Occurrence, temporal trends, and half-lives of perfluoroalkyl acids (PFAAs) in occupational workers in China","volume":"6","author":"Fu","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.tox.2025.154245_bib27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/toxsci\/kfab080","article-title":"\"Thyroid disruptors: extrathyroidal sites of chemical action and neurodevelopmental Outcome-An examination using triclosan and perfluorohexane sulfonate","volume":"183","author":"Gilbert","year":"2021","journal-title":"Toxicol. Sci."},{"issue":"12","key":"10.1016\/j.tox.2025.154245_bib28","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1172\/JCI107519","article-title":"\"Fuels, hormones, and liver metabolism at term and during the early postnatal period in the rat","volume":"52","author":"Girard","year":"1973","journal-title":"J. Clin. Invest"},{"issue":"12","key":"10.1016\/j.tox.2025.154245_bib29","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1039\/D0EM00291G","article-title":"\"An overview of the uses of per- and polyfluoroalkyl substances (PFAS)","volume":"22","author":"Gluge","year":"2020","journal-title":"Environ. Sci. Process Impacts"},{"issue":"10","key":"10.1016\/j.tox.2025.154245_bib30","doi-asserted-by":"crossref","first-page":"6133","DOI":"10.1021\/acs.est.1c02471","article-title":"\"Exposure to GenX and its novel analogs disrupts hepatic bile acid metabolism in Male mice","volume":"56","author":"Guo","year":"2022","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.tox.2025.154245_bib31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/toxsci\/61.2.201","article-title":"Statistical issues in the analysis of low-dose endocrine disruptor data","volume":"61","author":"Haseman","year":"2001","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2025.154245_bib32","unstructured":"Health Canada, 2024. Objective for Canadian drinking water quality per- and polyfluoroalkyl substances. https:\/\/www.canada.ca\/content\/dam\/hc-sc\/documents\/services\/publications\/healthy-living\/objective-drinking-water-quality-per-polyfluoroalkyl-substances\/objective-for-canadian-drinking-water-quality-en-final.pdf."},{"issue":"6","key":"10.1016\/j.tox.2025.154245_bib33","doi-asserted-by":"crossref","first-page":"67006","DOI":"10.1289\/EHP4093","article-title":"\"Tap water contributions to plasma concentrations of Poly- and perfluoroalkyl substances (PFAS) in a nationwide prospective cohort of U.S. Women","volume":"127","author":"Hu","year":"2019","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tox.2025.154245_bib34","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.toxrep.2019.06.016","article-title":"\"Toxicokinetics of perfluorobutane sulfonate (PFBS), perfluorohexane-1-sulphonic acid (PFHxS), and perfluorooctane sulfonic acid (PFOS) in Male and female Hsd:Sprague dawley SD rats after intravenous and gavage administration","volume":"6","author":"Huang","year":"2019","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.tox.2025.154245_bib35","series-title":"Interstate Technology & Regulatory Council, PFAS Team","article-title":"PFAS technical and regulatory guidance document and fact sheets PFAS-1","author":"ITRC","year":"2022"},{"key":"10.1016\/j.tox.2025.154245_bib36","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.fct.2016.09.017","article-title":"\"Gender differences in pharmacokinetics and tissue distribution of 3 perfluoroalkyl and polyfluoroalkyl substances in rats","volume":"97","author":"Kim","year":"2016","journal-title":"Food Chem. Toxicol."},{"issue":"1","key":"10.1016\/j.tox.2025.154245_bib37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41370-023-00626-x","article-title":"\"Per- and polyfluoroalkyl ether acids in well water and blood serum from private well users residing by a fluorochemical facility near fayetteville, north carolina","volume":"34","author":"Kotlarz","year":"2024","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"issue":"7","key":"10.1016\/j.tox.2025.154245_bib38","doi-asserted-by":"crossref","first-page":"77005","DOI":"10.1289\/EHP6837","article-title":"\"Measurement of novel, drinking Water-Associated PFAS in blood from adults and children in wilmington, north carolina","volume":"128","author":"Kotlarz","year":"2020","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tox.2025.154245_bib39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1472-6793-8-16","article-title":"\"Why we should use simpler models if the data allow this: relevance for ANOVA designs in experimental biology","volume":"8","author":"Lazic","year":"2008","journal-title":"BMC Physiol."},{"issue":"1","key":"10.1016\/j.tox.2025.154245_bib40","doi-asserted-by":"crossref","first-page":"6625","DOI":"10.1038\/s41598-020-63465-y","article-title":"\"Determining organ weight toxicity with Bayesian causal models: improving on the analysis of relative organ weights","volume":"10","author":"Lazic","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tox.2025.154245_bib41","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.toxlet.2018.09.001","article-title":"\"Serum concentrations of perfluorinated compounds among children living in sicily (Italy)","volume":"298","author":"Ledda","year":"2018","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.tox.2025.154245_bib42","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/oemed-2017-104651","article-title":"\"Half-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water","volume":"75","author":"Li","year":"2018","journal-title":"Occup. Environ. Med"},{"issue":"4","key":"10.1016\/j.tox.2025.154245_bib43","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"\"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.tox.2025.154245_bib44","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.chroma.2018.03.047","article-title":"\"Validation of quantitative measurements and semi-quantitative estimates of emerging perfluoroethercarboxylic acids (PFECAs) and hexfluoroprolyene oxide acids (HFPOAs)","volume":"1551","author":"McCord","year":"2018","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.tox.2025.154245_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.reprotox.2023.108421","article-title":"\"Reproductive and immune effects emerge at similar thresholds of PFHxS in deer mice","volume":"120","author":"Narizzano","year":"2023","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.tox.2025.154245_bib46","volume":"96","author":"NTP","year":"2022","journal-title":"NTP Tox"},{"issue":"9","key":"10.1016\/j.tox.2025.154245_bib47","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1289\/ehp.10009","article-title":"\"Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers","volume":"115","author":"Olsen","year":"2007","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tox.2025.154245_bib48","article-title":"\"The pollutant perfluorohexane sulfonate (PFHxS) reduces serum thyroxine but does not alter thyroid action in the postnatal rat brain","volume":"190","author":"O'Shaughnessy","year":"2024","journal-title":"Environ. Int"},{"issue":"3","key":"10.1016\/j.tox.2025.154245_bib49","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/etc.4863","article-title":"\"Recent US state and federal drinking water guidelines for Per- and polyfluoroalkyl substances","volume":"40","author":"Post","year":"2021","journal-title":"Environ. Toxicol. Chem."},{"issue":"2","key":"10.1016\/j.tox.2025.154245_bib50","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/toxsci\/kfy055","article-title":"\"Perfluorohexane sulfonate (PFHxS) and a mixture of endocrine disrupters reduce thyroxine levels and cause antiandrogenic effects in rats","volume":"163","author":"Ramhoj","year":"2018","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.tox.2025.154245_bib51","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1038\/s41598-020-59354-z","article-title":"\"Evaluating thyroid hormone disruption: investigations of long-term neurodevelopmental effects in rats after perinatal exposure to perfluorohexane sulfonate (PFHxS)","volume":"10","author":"Ramhoj","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.tox.2025.154245_bib52","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4103\/2230-8210.107851","article-title":"\"In utero fuel homeostasis: lessons for a clinician","volume":"17","author":"Rao","year":"2013","journal-title":"Indian J. Endocrinol. Metab."},{"key":"10.1016\/j.tox.2025.154245_bib53","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tox.2017.05.013","article-title":"\"PPARalpha-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling","volume":"387","author":"Rosen","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2025.154245_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2021.106843","article-title":"\"Exposure to a mixture of legacy, alternative, and replacement per- and polyfluoroalkyl substances (PFAS) results in sex-dependent modulation of cholesterol metabolism and liver injury","volume":"157","author":"Roth","year":"2021","journal-title":"Environ. Int"},{"issue":"12","key":"10.1016\/j.tox.2025.154245_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209255","article-title":"\"Temporal trends and predictors of perfluoroalkyl substances serum levels in Swedish pregnant women in the SELMA study","volume":"13","author":"Shu","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.tox.2025.154245_bib56","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.reprotox.2011.07.004","article-title":"\"Comparative pharmacokinetics of perfluorohexanesulfonate (PFHxS) in rats, mice, and monkeys","volume":"33","author":"Sundstrom","year":"2012","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.tox.2025.154245_bib57","unstructured":"US EPA \u201cIRIS toxicological review of perfluorohexansulfonic acid (PFHxS, CASRN 335-46-4) and related salts.\u201d EPA\/635\/R-25\/012Fa 2025."},{"issue":"7","key":"10.1016\/j.tox.2025.154245_bib58","doi-asserted-by":"crossref","first-page":"77004","DOI":"10.1289\/EHP6785","article-title":"\"Serum Half-Lives for Short- and Long-Chain perfluoroalkyl acids after ceasing exposure from drinking water contaminated by firefighting foam","volume":"128","author":"Xu","year":"2020","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tox.2025.154245_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2023.108014","article-title":"\"Developmental toxicity of perfluorohexane sulfonate at human relevant dose during pregnancy via disruption in placental lipid homeostasis","volume":"177","author":"Yao","year":"2023","journal-title":"Environ. Int"},{"key":"10.1016\/j.tox.2025.154245_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2025.117336","article-title":"\"Estimation of species- and sex-specific PFAS pharmacokinetics in mice, rats, and non-human primates using a Bayesian hierarchical methodology","volume":"499","author":"Zurlinden","year":"2025","journal-title":"Toxicol. Appl. Pharm."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X25002045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X25002045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T05:09:00Z","timestamp":1760591340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X25002045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":60,"alternative-id":["S0300483X25002045"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2025.154245","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maternal, fetal, and neonatal toxicity and potency estimates of perfluorohexane sulfonate (PFHxS) from oral maternal exposure in the Sprague-Dawley rat","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2025.154245","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"154245"}}